AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...
The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...
Takeda Canada Inc. (Takeda) is pleased to announce that Héma-Québec has added HyQvia®? (normal immunoglobulin [human] 10% and recombinant human hyaluronidase solution for subcutaneous infusion) as a ...
In preclinical animal trials, third-party testing results showed that AIM Vaccine's mRNA RSV vaccine achieved significantly higher levels of specific IgG antibody titers, live-virus neutralizing ...
HONG KONG SAR - Media OutReach Newswire – 5 February 2025 - AIM Vaccine Co., Ltd. (06660), a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory ...
Hosted on MSN3d
ADMA Loses 8.9% in a Month: How Should You Play the Stock?ADMA Biologics’ ADMA shares have lost 8.9% in a month against the industry’s growth of 6.6%. The company has put up a ...
Marine bivalves, which include many species worldwide, from intertidal zones to hydrothermal vents and cold seeps, are important components of the ecosystem and biodiversity. In their living habitats, ...
In patients with RCC, exceptional response to immunotherapy may be related to clonal neoantigen-driven cytotoxic T-cell ...
Generally, the immune system consists of two major arms, the innate and adaptive immunity, which are intertwined and closely regulate one another (44). Adaptive immunity, also called acquired immunity ...
Statistical analysis was carried out using the SPSS system for ... far as we know, the immune response to active immunisation of patients with RA treated with rituximab has not been studied before. We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback